Catalyst Wire Dossier Catalyst Wire Dossier

Siplizumab

siplizumab
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Siplizumab, covering 2025-05-29 to 2026-07-28. Get the full timeline:

Most recent: Clinical Trial Results: Siplizumab in T1DM [Phase 1, Phase 2]

See pricing